Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Centre, Prospective Cohort, Non-Interventional Study About Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients

NCT02430493 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02430493
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02430493 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Centre, Prospective Cohort, Non-Interventional Study About Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 28, 2015
Completion date
March 29, 2017
Enrollment
1,066 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome (acs)